Page last updated: 2024-09-02

tadalafil and Kahler Disease

tadalafil has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borrello, I; Bui, M; Ghosh, N; Noonan, KA; Rudraraju, L	1

Other Studies

1 other study(ies) available for tadalafil and Kahler Disease

Article	Year
Targeting immune suppression with PDE5 inhibition in end-stage multiple myeloma. Cancer immunology research, 2014, Volume: 2, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Carbolines; Clarithromycin; Dexamethasone; Humans; Immune Tolerance; Immunologic Factors; Interleukin-4 Receptor alpha Subunit; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Myeloid Cells; Phosphodiesterase 5 Inhibitors; T-Lymphocytes; Tadalafil; Thalidomide	2014

Article

Year

Targeting immune suppression with PDE5 inhibition in end-stage multiple myeloma.

Cancer immunology research, 2014, Volume: 2, Issue:8

Topics: Antineoplastic Combined Chemotherapy Protocols; Carbolines; Clarithromycin; Dexamethasone; Humans; Immune Tolerance; Immunologic Factors; Interleukin-4 Receptor alpha Subunit; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Myeloid Cells; Phosphodiesterase 5 Inhibitors; T-Lymphocytes; Tadalafil; Thalidomide

2014